[
  {
    "date": "2023-12-30",
    "symbol": "ONCT",
    "period": "FY",
    "netincomeloss": -39479000,
    "entityregistrantname": "Oncternal Therapeutics, Inc.",
    "entitycentralindexkey": 1260990,
    "documenttype": "10-K",
    "documentperiodenddate": "2023-12-31",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ONCT",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "000-50549",
    "entitytaxidentificationnumber": "62-1715807",
    "entityaddressaddressline1": "12230 El Camino Real",
    "entityaddressaddressline2": "Suite 230",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "434-1113",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "BDO USA, P.C.",
    "auditorlocation": "San Diego, California",
    "auditorfirmid": 243,
    "cashandcashequivalentsatcarryingvalue": 6697000,
    "shortterminvestments": 27558000,
    "prepaidexpenseandotherassetscurrent": 1804000,
    "assetscurrent": 36059000,
    "operatingleaserightofuseasset": 258000,
    "otherassetsnoncurrent": 412000,
    "assets": 36729000,
    "accountspayablecurrent": 1148000,
    "accruedliabilitiescurrent": 3877000,
    "operatingleaseliabilitycurrent": 173000,
    "liabilitiescurrent": 5198000,
    "deferredcompensationliabilitycurrentandnoncurrent": 1334000,
    "operatingleaseliabilitynoncurrent": 145000,
    "liabilities": 6677000,
    "commonstockvalue": 3000,
    "additionalpaidincapital": 227825000,
    "accumulatedothercomprehensiveincomelossnetoftax": 3000,
    "retainedearningsaccumulateddeficit": -197779000,
    "stockholdersequity": 30052000,
    "liabilitiesandstockholdersequity": 36729000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 2948000,
    "commonstocksharesoutstanding": 2948000,
    "revenues": 785000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 29753000,
    "generalandadministrativeexpense": 12746000,
    "operatingexpenses": 42499000,
    "operatingincomeloss": -41714000,
    "investmentincomeinterest": 2235000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": -6000,
    "comprehensiveincomenetoftax": -39485000,
    "earningspersharebasic": -13.43,
    "earningspersharediluted": -13.43,
    "weightedaveragenumberofsharesoutstandingbasic": 2940000,
    "weightedaveragenumberofdilutedsharesoutstanding": 2940000,
    "profitloss": -39479000,
    "sharebasedcompensation": 7500000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 1633000,
    "noncashleaseexpense": 174000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -2624000,
    "increasedecreaseinaccountspayable": -1769000,
    "increasedecreaseinaccruedliabilities": -801000,
    "increasedecreaseindeferredcompensation": 1334000,
    "increasedecreaseinoperatingleaseliability": -114000,
    "netcashprovidedbyusedinoperatingactivities": -32164000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 64349000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 65000000,
    "netcashprovidedbyusedininvestingactivities": 651000,
    "proceedsfromissuanceofcommonstock": 1224000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 156000,
    "netcashprovidedbyusedinfinancingactivities": 1068000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -30445000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 6697000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 345000,
    "issuanceofcommonstockandwarrantsnetofissuancecosts": 1224000,
    "issuanceofcommonstockandwarrantsnetofissuancecostsshares": 55000,
    "restrictedstockvaluesharesissuednetoftaxwithholdings": -156000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 30000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": -11000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7500000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -6000,
    "paymentsofstockissuancecosts": 38000,
    "cashandcashequivalentsatcarryingvalueandshortterminvestments": 34300000,
    "stockissuedduringperiodsharesnewissues": 38800000,
    "saleofstocknumberofsharesissuedintransaction": 55274,
    "saleofstockconsiderationreceivedontransaction": 1200000,
    "numberofoperatingsegments": 1,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 170521,
    "prepaidresearchanddevelopmentexpense": 312000,
    "prepaidclinicaltrialsexpense": 294000,
    "prepaidinsurance": 478000,
    "otherprepaidexpensecurrent": 88000,
    "accountsreceivablenet": 139000,
    "otherreceivablesnetcurrentincludinggrant": 493000,
    "prepaidexpensecurrent": 1804000,
    "accruedresearchanddevelopmentexpenses": 146000,
    "accruedclinicaltrials": 2018000,
    "accruedprofessionalfeescurrent": 134000,
    "employeerelatedliabilitiescurrent": 1579000,
    "maturitysecuritiesdebtmaturitiesperiod1": "P1Y",
    "availableforsaledebtsecuritiesamortizedcostbasis": 23840000,
    "availableforsaledebtsecuritiesgrossunrealizedgain": 4000,
    "availableforsaledebtsecuritiesgrossunrealizedloss": 1000,
    "availableforsalesecuritiesdebtsecurities": 23844000,
    "debtsecuritiesavailableforsaleaccruedinterestafterallowanceforcreditlossstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#Assets",
    "debtsecuritiesavailableforsaleaccruedinterestafterallowanceforcreditloss": 15000,
    "rentexpense": 200000,
    "lesseeoperatingleasediscountrate": 0.1,
    "operatingleaseliability": 300000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y9M18D",
    "proceedsfromcollaborators": 500000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 196000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 150000,
    "lesseeoperatingleaseliabilitypaymentsdue": 346000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 28000,
    "numberofdaysinwrittennoticeoftermination": "P60D",
    "researchanddevelopmentexpense": 200000,
    "researchanddevelopmentgrants": 4000000,
    "otherresearchanddevelopmentexpense": 500000,
    "accruedclinicaltrials1": 1000000,
    "awardpaymentsreceived": 800000,
    "unbilledcontractsreceivable": 500000,
    "investmentsfairvaluedisclosure": 23844000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 170521000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 74,
    "classofwarrantweightedaverageremainingcontractualterm": "P1Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 97708,
    "sharebasedcompensationarrangementpercentageofannualincreaseinsharesreservedforissuance": 0.05,
    "commonstockcapitalsharesreservedforfutureissuance": 94909,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 13.33,
    "allocatedsharebasedcompensationexpense": 4064000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 548073000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 173794000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 51487000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 548073000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisablenumber": 279184000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 56.51,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 16.49,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 69.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 56.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableweightedaverageexerciseprice": 74.09,
    "weightedaveragecontractualtermoutstanding": "P7Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableweightedaverageremainingcontractualterm": "P7Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 155648000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 155648000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableintrinsicvalue": 68418000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 18557000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 30537000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedorrepurchasedinperiod": 1344000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P0Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 28.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 35.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.041,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 7700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P1Y10M24D",
    "commonstockwarrantsreservedforfutureissuance": 170521,
    "commonstockoptionsoutstandingforfutureissuance": 548073,
    "restrictedstockunitawardsunvestedandoutstandingforfutureissuance": 18557,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -8290000,
    "incometaxreconciliationstateandlocalincometaxes": -58000,
    "incometaxreconciliationpermanentitems": 8000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 1172000,
    "incometaxreconciliationtaxcreditsresearch": 2910000,
    "incometaxreconciliationchangeinenactedtaxrate": 1222000,
    "incometaxreconciliationotheradjustments": 196000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 8660000,
    "deferredtaxassetsoperatinglosscarryforwards": 29997000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 10958000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 676000,
    "deferredtaxassetsinprocessresearchanddevelopment": 22501000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2406000,
    "deferredtaxassetsother": 90000,
    "deferredtaxassetsnet": 66628000,
    "deferredtaxassetsvaluationallowance": 66561000,
    "deferredtaxassetsliabilitiesnet": 67000,
    "deferredtaxliabilitiesrightofuseasset": 67000,
    "deferredincometaxliabilities": 67000,
    "valuationallowancedeferredtaxassetchangeinamount": 8700000,
    "operatinglosscarryforwards": 119500000,
    "operatinglosscarryforwardsnonexpireportion": 93200000,
    "operatinglosscarryforwardsexpirationyear": 2033,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2034
  },
  {
    "date": "2022-12-30",
    "symbol": "ONCT",
    "period": "FY",
    "entityregistrantname": "Oncternal Therapeutics, Inc.",
    "entitycentralindexkey": 1260990,
    "documenttype": "10-K",
    "documentperiodenddate": "2022-12-31",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ONCT",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "000-50549",
    "entitytaxidentificationnumber": "62-1715807",
    "entityaddressaddressline1": "12230 El Camino Real",
    "entityaddressaddressline2": "Suite 230",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "434-1113",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "BDO USA, LLP",
    "auditorlocation": "San Diego, California",
    "auditorfirmid": 243,
    "cashandcashequivalentsatcarryingvalue": 37142000,
    "shortterminvestments": 26582000,
    "prepaidexpenseandotherassetscurrent": 3566000,
    "assetscurrent": 67290000,
    "operatingleaserightofuseasset": 87000,
    "otherassetsnoncurrent": 1274000,
    "assets": 68651000,
    "accountspayablecurrent": 2917000,
    "accruedliabilitiescurrent": 4678000,
    "operatingleaseliabilitycurrent": 87000,
    "liabilitiescurrent": 7682000,
    "commonstockvalue": 57000,
    "additionalpaidincapital": 219203000,
    "accumulatedothercomprehensiveincomelossnetoftax": 9000,
    "retainedearningsaccumulateddeficit": -158300000,
    "stockholdersequity": 60969000,
    "liabilitiesandstockholdersequity": 68651000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 57464000,
    "commonstocksharesoutstanding": 57464000,
    "revenues": 1490000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 32980000,
    "generalandadministrativeexpense": 13457000,
    "operatingexpenses": 46437000,
    "operatingincomeloss": -44947000,
    "investmentincomeinterest": 777000,
    "netincomeloss": -44170000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": 9000,
    "comprehensiveincomenetoftax": -44161000,
    "earningspersharebasic": -0.84,
    "earningspersharediluted": -0.84,
    "weightedaveragenumberofsharesoutstandingbasic": 52594000,
    "weightedaveragenumberofdilutedsharesoutstanding": 52594000,
    "profitloss": -44170000,
    "sharebasedcompensation": 7431000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 75000,
    "noncashleaseexpense": 179000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2095000,
    "increasedecreaseinaccountspayable": 958000,
    "increasedecreaseinaccruedliabilities": 1247000,
    "increasedecreaseinoperatingleaseliability": -179000,
    "netcashprovidedbyusedinoperatingactivities": -36704000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 26498000,
    "netcashprovidedbyusedininvestingactivities": -26498000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 3000,
    "proceedsfromissuanceofcommonstock": 9582000,
    "netcashprovidedbyusedinfinancingactivities": 9579000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -53623000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 37142000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 191000,
    "issuanceofcommonstockandwarrantsnetofissuancecosts": 8000,
    "issuanceofcommonstockandwarrantsnetofissuancecostsshares": 8031000,
    "restrictedstockvaluesharesissuednetoftaxwithholdings": -3000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 6000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": -2000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7431000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 9000,
    "paymentsofstockissuancecosts": 375000,
    "cashandcashequivalentsatcarryingvalueandshortterminvestments": 63700000,
    "stockissuedduringperiodsharesnewissues": 40000000,
    "saleofstocknumberofsharesissuedintransaction": 8031355,
    "saleofstockconsiderationreceivedontransaction": 9600000,
    "accruedclinicaltrials": 868000,
    "numberofoperatingsegments": 1,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3411000,
    "prepaidclinicaltrialsexpense": 2616000,
    "prepaidinsurance": 669000,
    "otherprepaidexpensecurrent": 103000,
    "otherreceivablesnetcurrentincludinggrant": 178000,
    "prepaidexpensecurrent": 3566000,
    "accruedresearchanddevelopmentexpenses": 972000,
    "accruedprofessionalfeescurrent": 138000,
    "employeerelatedliabilitiescurrent": 2691000,
    "otheraccruedliabilitiescurrent": 9000,
    "availableforsalesecuritiesdebtsecurities": 37100000,
    "maturitysecuritiesdebtmaturitiesperiod": "P1Y",
    "availableforsaledebtsecuritiesamortizedcostbasis": 25108000,
    "availableforsaledebtsecuritiesgrossunrealizedgain": 7000,
    "rentexpense": 200000,
    "lesseeoperatingleasediscountrate": 0.1,
    "operatingleaseliability": 87000000,
    "operatingleaseweightedaverageremainingleaseterm1": "P0Y7M6D",
    "numberofdaysinwrittennoticeoftermination": "P90D",
    "numberofdaysafterreceiptofnoticetopayfailureamount": "P30D",
    "numberofdaysafterreceiptofnoticefordefaultinpayment": "P60D",
    "minimumperiodofwrittennoticetoterminateagreement": "P60D",
    "researchanddevelopmentexpense": 500000,
    "researchagreementterm": "P5Y",
    "researchagreementresearchfundingamountpayable": 3600000,
    "otherresearchanddevelopmentexpense": 500000,
    "subawardpaymentsreceived": 700000,
    "relatedqualifyingsubawardcosts": 500000,
    "awardpaymentsreceived": 1100000,
    "unbilledcontractsreceivable": 100000,
    "cashandcashequivalentsfairvaluedisclosure": 25108000,
    "investmentsfairvaluedisclosure": 21688000,
    "assetsfairvaluedisclosure": 55677000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 3410642000,
    "warrantsexpired": 824268000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.7,
    "warrantexpiredpricepershare": 38.64,
    "classofwarrantweightedaverageremainingcontractualterm": "P2Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 1954150,
    "sharebasedcompensationarrangementpercentageofannualincreaseinsharesreservedforissuance": 0.05,
    "commonstockcapitalsharesreservedforfutureissuance": 1230000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8515696000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2790518000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 719566000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8515696000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisablenumber": 3437688000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 4.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableweightedaverageexerciseprice": 4.88,
    "weightedaveragecontractualtermoutstanding": "P8Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableweightedaverageremainingcontractualterm": "P7Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 101611000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 101611000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableintrinsicvalue": 82077000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1009083000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1056507000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 6494000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedorrepurchasedinperiod": 40930000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P0Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 2.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 1.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.022,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.005,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M6D",
    "allocatedsharebasedcompensationexpense": 4055000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 12600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P2Y7M6D",
    "commonstockwarrantsreservedforfutureissuance": 3411000,
    "commonstockoptionsoutstandingforfutureissuance": 8516000,
    "restrictedstockunitawardsunvestedandoutstandingforfutureissuance": 1009000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -9276000,
    "incometaxreconciliationstateandlocalincometaxes": -2820000,
    "incometaxreconciliationpermanentitems": 3000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 831000,
    "incometaxreconciliationtaxcreditsresearch": 4747000,
    "incometaxreconciliationotheradjustments": -48000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 16057000,
    "deferredtaxassetsoperatinglosscarryforwards": 27889000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 7804000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 860000,
    "deferredtaxassetsinprocessresearchanddevelopment": 19153000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2188000,
    "deferredtaxassetsother": 29000,
    "deferredtaxassetsnet": 57923000,
    "deferredtaxassetsvaluationallowance": 57899000,
    "deferredtaxassetsliabilitiesnet": 24000,
    "deferredtaxliabilitiesrightofuseasset": 24000,
    "deferredincometaxliabilities": 24000,
    "valuationallowancedeferredtaxassetchangeinamount": 16100000,
    "operatinglosscarryforwards": 99100000,
    "operatinglosscarryforwardsnonexpireportion": 72800000,
    "operatinglosscarryforwardsexpirationyear": 2033,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2034,
    "cumulativechangeinownershippercentage": 0.5,
    "periodforcumulativechangeinownership": "P3Y"
  },
  {
    "date": "2021-12-30",
    "symbol": "ONCT",
    "period": "FY",
    "entityregistrantname": "Oncternal Therapeutics, Inc.",
    "entitycentralindexkey": 1260990,
    "documenttype": "10-K",
    "documentperiodenddate": "2021-12-31",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ONCT",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "000-50549",
    "entitytaxidentificationnumber": "62-1715807",
    "entityaddressaddressline1": "12230 El Camino Real",
    "entityaddressaddressline2": "Suite 300",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "434-1113",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "BDO USA, LLP",
    "auditorlocation": "San Diego, California",
    "auditorfirmid": 243,
    "cashandcashequivalentsatcarryingvalue": 90765000,
    "prepaidexpenseandotherassetscurrent": 2088000,
    "assetscurrent": 92853000,
    "operatingleaserightofuseasset": 75000,
    "otherassetsnoncurrent": 657000,
    "assets": 93585000,
    "accountspayablecurrent": 1959000,
    "accruedliabilitiescurrent": 3431000,
    "deferredrevenue": 1600000,
    "operatingleaseliabilitycurrent": 75000,
    "liabilitiescurrent": 5465000,
    "commonstockvalue": 49000,
    "additionalpaidincapital": 202201000,
    "retainedearningsaccumulateddeficit": -114130000,
    "stockholdersequity": 88120000,
    "liabilitiesandstockholdersequity": 93585000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 49429000,
    "commonstocksharesoutstanding": 49429000,
    "revenues": 4315000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 24086000,
    "generalandadministrativeexpense": 11595000,
    "operatingexpenses": 35681000,
    "operatingincomeloss": -31366000,
    "othernonoperatingincome": 300000,
    "investmentincomeinterest": 33000,
    "othernonoperatingincomeexpense": 33000,
    "netincomeloss": -31333000,
    "earningspersharebasicanddiluted": -0.64,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 49321000,
    "profitloss": -31333000,
    "sharebasedcompensation": 5875000,
    "noncashleaseexpense": 169000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 713000,
    "increasedecreaseinaccountspayable": 816000,
    "increasedecreaseinaccruedliabilities": 399000,
    "increasedecreaseinoperatingleaseliability": -169000,
    "increasedecreaseindeferredrevenue": -1633000,
    "netcashprovidedbyusedinoperatingactivities": -26589000,
    "proceedsfromstockoptionsexercisedandwarrantexercises": 617000,
    "netcashprovidedbyusedinfinancingactivities": 617000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -25972000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 90765000,
    "cashlessexerciseofwarrants": 1836000,
    "stockissuedduringperiodvaluestockoptionsexercised": 415000,
    "stockissuedduringperiodsharesstockoptionsexercised": 108000,
    "exerciseofcashlesswarrantshares": 459000,
    "adjustmentstoadditionalpaidincapitalexerciseofwarrantstopurchasecommonstockforcash": 202000,
    "adjustmentstoadditionalpaidincapitalexerciseofwarrantstopurchasecommonstockforcashshares": 60000,
    "adjustmentstoadditionalpaidincapitalvestingrelatedtounvestedshareliability": 10000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5875000,
    "stockissuedduringperiodsharesnewissues": 50000,
    "accruedclinicaltrials": 500000,
    "grantsreceivable": 400000,
    "numberofoperatingsegments": 1,
    "weightedaveragenumberofsharescommonstocksubjecttorepurchaseorcancellation": 7000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4235000,
    "accruedresearchanddevelopmentexpenses": 779000,
    "accruedprofessionalfeescurrent": 154000,
    "employeerelatedliabilitiescurrent": 1955000,
    "otheraccruedliabilitiescurrent": 25000,
    "rentexpense": 200000,
    "lesseeoperatingleasediscountrate": 0.1,
    "operatingleaseliability": 75000,
    "operatingleaseweightedaverageremainingleaseterm1": "P0Y5M1D",
    "generalinsuranceexpense": 1800000,
    "insurancecommissions": 100000,
    "accountsreceivablerelatedparties": 400000,
    "numberofdaysinwrittennoticeoftermination": "P90D",
    "numberofdaysafterreceiptofnoticetopayfailureamount": "P30D",
    "numberofdaysafterreceiptofnoticefordefaultinpayment": "P60D",
    "minimumperiodofwrittennoticetoterminateagreement": "P60D",
    "researchanddevelopmentexpense": 100000,
    "researchagreementterm": "P5Y",
    "researchagreementresearchfundingamount": 3600000,
    "subawardpaymentsreceived": 2200000,
    "relatedqualifyingsubawardcosts": 8800000,
    "awardpaymentsreceived": 143000000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 4234910000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 10.5,
    "amountforatthemarketfacility": 50000000,
    "exerciseofwarrants": -796931000,
    "warrantexercisedpricepershare": 2.56,
    "classofwarrantweightedaverageremainingcontractualterm": "P3Y3M22D",
    "commonstockcapitalsharesreservedforfutureissuance": 1842432000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 419755000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6444744000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4884800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 439684000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisablenumber": 1440122000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.28,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.78,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.46,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableweightedaverageexerciseprice": 3.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableweightedaverageremainingcontractualterm": "P6Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 613190000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableintrinsicvalue": 488187000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.009,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.928,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y2M12D",
    "allocatedsharebasedcompensationexpense": 3136000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 17400000,
    "commonstockwarrantsreservedforfutureissuance": 4235000,
    "commonstockoptionsissuedandoutstandingforfutureissuance": 6445000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -6579000,
    "incometaxreconciliationstateandlocalincometaxes": -2013000,
    "incometaxreconciliationpermanentitems": 4000,
    "incometaxeffectsallocateddirectlytoequityemployeestockoptions": 512000,
    "incometaxreconciliationtaxcreditsresearch": 1099000,
    "incometaxreconciliationotheradjustments": -131000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 9306000,
    "deferredtaxassetsoperatinglosscarryforwards": 21254000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3051000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 484000,
    "deferredtaxassetsinprocessresearchanddevelopment": 15847000,
    "deferredtaxassetsother": 24000,
    "deferredtaxassetsnet": 41866000,
    "deferredtaxassetsvaluationallowance": 41845000,
    "deferredtaxassetsliabilitiesnet": 21000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1206000,
    "deferredtaxliabilitiesrightofuseasset": 21000,
    "deferredincometaxliabilities": 21000,
    "valuationallowancedeferredtaxassetchangeinamount": 9300000,
    "operatinglosscarryforwards": 81500000,
    "operatinglosscarryforwardsnonexpireportion": 55200000,
    "operatinglosscarryforwardsexpirationyear": 2033,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2034,
    "cumulativechangeinownershippercentage": 0.5,
    "periodforcumulativechangeinownership": "P3Y"
  },
  {
    "date": "2020-12-30",
    "symbol": "ONCT",
    "period": "FY",
    "entityregistrantname": "Oncternal Therapeutics, Inc.",
    "entitycentralindexkey": 1260990,
    "documenttype": "10-K",
    "documentperiodenddate": "December 31, 2020",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ONCT",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "000-50549",
    "entitytaxidentificationnumber": "62-1715807",
    "entityaddressaddressline1": "12230 El Camino Real",
    "entityaddressaddressline2": "Suite 300",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "434-1113",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "Nasdaq",
    "entityincorporationstatecountrycode": "Delaware",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 116737000,
    "otherprepaidexpensecurrent": 1266000,
    "assetscurrent": 118003000,
    "operatingleaserightofuseasset": 40000,
    "otherassetsnoncurrent": 766000,
    "assets": 118809000,
    "accountspayablecurrent": 1143000,
    "accruedliabilitiescurrent": 3042000,
    "deferredrevenue": 1633000,
    "operatingleaseliabilitycurrent": 40000,
    "liabilitiescurrent": 5858000,
    "commonstockvalue": 49000,
    "additionalpaidincapital": 195699000,
    "retainedearningsaccumulateddeficit": -82797000,
    "stockholdersequity": -82797000,
    "liabilitiesandstockholdersequity": 118809000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 60000000,
    "commonstocksharesissued": 48802000,
    "commonstocksharesoutstanding": 48802,
    "revenues": 3400000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 12544000,
    "generalandadministrativeexpense": 200000,
    "operatingexpenses": 20917000,
    "operatingincomeloss": -17542000,
    "othernonoperatingincome": 301000,
    "investmentincomeinterest": 16000,
    "othernonoperatingincomeexpense": 317000,
    "netincomeloss": -17225000,
    "earningspersharebasicanddiluted": -0.85,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 20305,
    "profitloss": -17225000,
    "noncashorpartnoncashgainlossofforgivenessofpayrollprotectionloan": 301000,
    "sharebasedcompensation": 1556000,
    "noncashleaseexpense": 150000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 529000,
    "increasedecreaseinaccountspayable": 272000,
    "increasedecreaseinaccruedliabilities": 739000,
    "increasedecreaseinoperatingleaseliability": -150000,
    "increasedecreaseindeferredrevenue": -2007000,
    "netcashprovidedbyusedinoperatingactivities": -17495000,
    "proceedsfromissuanceoflongtermdebt": 301000,
    "proceedsfromstockoptionsexercisedandwarrantexercises": 4000,
    "proceedsfromissuanceofcommonstock": 113876000,
    "netcashprovidedbyusedinfinancingactivities": 114181000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 96686000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 116737000,
    "stockissued1": 415000,
    "fairvalueofwarrantsissuedtoplacementagent": 5325000,
    "stockissuedduringperiodvaluestockoptionsexercised": 4000,
    "stockissuedduringperiodsharesstockoptionsexercised": 5135,
    "exerciseofcashlesswarrantshares": 36,
    "adjustmentstoadditionalpaidincapitalvestingrelatedtounvestedshareliability": 13000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 113876000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecostsshares": 33374,
    "issuanceofbonusawardswithstockoptioninlieuofcash": 415000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1556000,
    "paymentsofstockissuancecosts": 11103000,
    "accruedclinicaltrials": 1000000,
    "numberofoperatingsegments": 1,
    "weightedaveragenumberofsharescommonstocksubjecttorepurchaseorcancellation": 25000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7273,
    "accruedresearchanddevelopmentexpenses": 412000,
    "accruedprofessionalfeescurrent": 77000,
    "accruedunvestedshareliability": 10000,
    "employeerelatedliabilitiescurrent": 1528000,
    "otheraccruedliabilitiescurrent": 35000,
    "leaseandrentalexpense": 200000,
    "lesseeoperatingleasediscountrate": 0.1,
    "operatingleaseliability": 40000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3M",
    "generalinsuranceexpense": 1400000,
    "insurancecommissions": 100000,
    "accountsreceivablerelatedparties": 300000,
    "numberofdaysinwrittennoticeoftermination": 60,
    "numberofdaysafterreceiptofnoticetopayfailureamount": 30,
    "numberofdaysafterreceiptofnoticefordefaultinpayment": 60,
    "minimumperiodofwrittennoticetoterminateagreement": 60,
    "researchanddevelopmentexpense": 200000,
    "researchagreementterm": "P5Y",
    "researchagreementresearchfundingamount": 3600000,
    "researchagreementresearchfundingamountpayable": 125000,
    "subawardpaymentsreceived": 1400000,
    "relatedqualifyingsubawardcosts": 5200000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": "null",
    "combinedpurchasepriceofshareandwarrantperunit": 4.5,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 9.25,
    "exerciseofwarrantsissued": "null",
    "exerciseofwarrants": -74781,
    "warrantissuedpricepershare": 3.47,
    "warrantexercisedpricepershare": 3.22,
    "classofwarrantweightedaverageremainingcontractualterm": "P4Y4M24D",
    "liabilityforunvestedcashsettledsharebasedpaymenttransactions": 10000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 15000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 20000,
    "commonstockcapitalsharesreservedforfutureissuance": 8196000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 111145,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 63.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 173753,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisablenumber": 118024,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableweightedaverageexerciseprice": 75.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.53,
    "sharesissuedpricepershare": 4.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 965129,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 2.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2509000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 2509000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 1525000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 624260,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.37,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.006999999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9159999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y8M12D",
    "allocatedsharebasedcompensationexpense": 1556000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 3400000,
    "commonstockwarrantsreservedforfutureissuance": 5032000,
    "commonstockoptionsissuedandoutstandingforfutureissuance": 2226000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -3617000,
    "incometaxreconciliationstateandlocalincometaxes": -1113000,
    "incometaxreconciliationpermanentitems": -65000,
    "incometaxreconciliationtaxcreditsresearch": 505000,
    "incometaxreconciliationotheradjustments": 226000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 5074000,
    "deferredtaxassetsoperatinglosscarryforwards": 17852000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 900000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 367000,
    "deferredtaxassetsinprocessresearchanddevelopment": 11987000,
    "deferredtaxassetsother": 393000,
    "deferredtaxassetsnet": 32551000,
    "deferredtaxassetsvaluationallowance": 32540000,
    "deferredtaxassetsliabilitiesnet": 11000,
    "deferredtaxliabilitiesrightofuseasset": 11000,
    "deferredincometaxliabilities": 11000,
    "valuationallowancedeferredtaxassetchangeinamount": 13100000,
    "valuationallowancedeferredtaxassetchangenetamount": 13100000,
    "operatinglosscarryforwards": 47700000,
    "operatinglosscarryforwardsnonexpireportion": 43400000,
    "operatinglosscarryforwardsexpirationyear": 2029,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2034,
    "cumulativechangeinownershippercentage": 0.5,
    "periodforcumulativechangeinownership": "P3Y"
  },
  {
    "date": "2019-12-30",
    "symbol": "ONCT",
    "period": "FY",
    "entityregistrantname": "Oncternal Therapeutics, Inc.",
    "entitycentralindexkey": 1260990,
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ONCT",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilenumber": "000-50549",
    "entitytaxidentificationnumber": "62-1715807",
    "entityaddressaddressline1": "12230 El Camino Real",
    "entityaddressaddressline2": "Suite 300",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "434-1113",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 20051000,
    "prepaidexpenseandotherassetscurrent": 736000,
    "assetscurrent": 20787000,
    "operatingleaserightofuseasset": 190000,
    "otherassetsnoncurrent": 767000,
    "assets": 21744000,
    "accountspayablecurrent": 871000,
    "accruedliabilitiescurrent": 2731000,
    "deferredrevenue": 3640000,
    "operatingleaseliabilitycurrent": 99000,
    "liabilitiescurrent": 7341000,
    "preferredstockwarrantliability": 1300000,
    "operatingleaseliabilitynoncurrent": 91000,
    "commonstockvalue": 15000,
    "additionalpaidincapital": 79869000,
    "retainedearningsaccumulateddeficit": -65572000,
    "stockholdersequity": -65572000,
    "liabilitiesandstockholdersequity": 21744000,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 60000000,
    "commonstocksharesissued": 15387000,
    "commonstocksharesoutstanding": 15387,
    "revenues": 2400000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 10159000,
    "researchanddevelopmentinprocess": 18088000,
    "generalandadministrativeexpense": 200000,
    "operatingexpenses": 35533000,
    "operatingincomeloss": -33108000,
    "fairvalueadjustmentofwarrants": 1268000,
    "investmentincomeinterest": 188000,
    "othernonoperatingincomeexpense": -1080000,
    "netincomeloss": -34188000,
    "earningspersharebasicanddiluted": -3.31,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 10329,
    "profitloss": -34188000,
    "sharebasedcompensation": 507000,
    "noncashleaseexpense": 92000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 44000,
    "increasedecreaseinaccountspayable": -4762000,
    "increasedecreaseinaccruedliabilities": -1255000,
    "increasedecreaseinoperatingleaseliability": -92000,
    "increasedecreaseindeferredrevenue": 3640000,
    "netcashprovidedbyusedinoperatingactivities": -16746000,
    "cashacquiredfromacquisition": 18292000,
    "paymentstoacquirebusinessesgross": 2155000,
    "netcashprovidedbyusedininvestingactivities": 16137000,
    "proceedsfromstockoptionsexercised": 14000,
    "proceedsfromwarrantexercises": 1000,
    "netcashprovidedbyusedinfinancingactivities": 15000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -594000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 20051000,
    "conversionofconvertiblepreferredstocktocommonstock": 46588000,
    "stockissued1": 29049000,
    "reclassificationofpreferredstockwarrantsliabilitytoadditionalpaidincapital": 1942000,
    "noncashorpartnoncashacquisitionvalueofliabilitiesassumed1": 5177000,
    "stockissuedduringperiodvaluestockoptionsexercised": 14000,
    "stockissuedduringperiodsharesstockoptionsexercised": 19040,
    "adjustmentstoadditionalpaidincapitalexerciseofwarrantstopurchasecommonstockforcash": 1000,
    "adjustmentstoadditionalpaidincapitalvestingrelatedtorepurchaseliabilitynet": 30000,
    "stockissuedduringperiodvalueacquisitions": 29049000,
    "stockissuedduringperiodsharesacquisitions": 3458,
    "stockissuedduringperiodvalueconversionofconvertiblesecuritiesnetofadjustments": 46588000,
    "temporaryequitystockissuedduringperiodsharesconversionofconvertiblesecurities": 8148,
    "temporaryequitystockissuedduringperiodvalueconversionofconvertiblesecurities": -46588000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 8148,
    "adjustmentstoadditionalpaidincapitalreclassificationofconvertiblepreferredstockwarrant": 1942000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 507000,
    "numberofoperatingsegments": 1,
    "weightedaveragenumberofsharescommonstocksubjecttorepurchaseorcancellation": 56000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.69,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 1268000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": 1942000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2834,
    "accruedresearchanddevelopmentexpenses": 1206000,
    "accruedprofessionalfeescurrent": 424000,
    "accruedunvestedshareliability": 24000,
    "employeerelatedliabilitiescurrent": 825000,
    "otheraccruedliabilitiescurrent": 252000,
    "leaseandrentalexpense": 100000,
    "lesseeoperatingleasediscountrate": 0.1,
    "operatingleaseliability": 190000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y3M",
    "generalinsuranceexpense": 1200000,
    "insurancecommissions": 100000,
    "expenseonservicesrelatedtopotentialoutlicensingorsaleoftechnology": 3500,
    "accountsreceivablerelatedparties": 200000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 166000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 41000,
    "lesseeoperatingleaseliabilitypaymentsdue": 207000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 17000,
    "numberofdaysinwrittennoticeoftermination": "P60D",
    "numberofdaysafterreceiptofnoticetopayfailureamount": "P30D",
    "numberofdaysafterreceiptofnoticefordefaultinpayment": "P60D",
    "minimumperiodofwrittennoticetoterminateagreement": "P60D",
    "researchanddevelopmentexpense": 100000,
    "researchagreementterm": "P5Y",
    "researchagreementresearchfundingamount": 3600000,
    "researchagreementresearchfundingamountpayable": 125000,
    "percentageofdevotingbusinessactivities": 0.8,
    "subawardpaymentsreceived": 6200000,
    "relatedqualifyingsubawardcosts": 5400000,
    "warrantsissuedexpirationperiod": "The warrants expire on various dates in September, November and December 2022.",
    "numberofcommonstockwarrantsexercised": 196,
    "liabilityforunvestedcashsettledsharebasedpaymenttransactions": 24000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 35000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 65000,
    "commonstockcapitalsharesreservedforfutureissuance": 3294000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 257067,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 59.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 52726,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisablenumber": 295414,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableweightedaverageexerciseprice": 71.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingandexercisableweightedaverageremainingcontractualterm1": "P8M12D",
    "sharesissuedpricepershare": 3.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1662253,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 244170,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 1.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P3Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P9Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1460000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 1460000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 718000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1230000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.47,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.38,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.776,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "allocatedsharebasedcompensationexpense": 507000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4200000,
    "commonstockwarrantsreservedforfutureissuance": 841000,
    "commonstockoptionsissuedandoutstandingforfutureissuance": 1958000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -7179000,
    "incometaxreconciliationstateandlocalincometaxes": -968000,
    "incometaxreconciliationpermanentitems": 873000,
    "incometaxreconciliationinprocessresearchanddevelopment": 3354000,
    "incometaxreconciliationtaxcreditsresearch": 217000,
    "incometaxreconciliationotheradjustments": 18000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 4119000,
    "deferredtaxassetsoperatinglosscarryforwards": 18108000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 700000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 214000,
    "deferredtaxassetsinprocessresearchanddevelopment": 7688000,
    "deferredtaxassetsother": 143000,
    "deferredtaxassetsnet": 27599000,
    "deferredtaxassetsvaluationallowance": 27546000,
    "deferredtaxassetsliabilitiesnet": 53000,
    "deferredtaxliabilitiesrightofuseasset": 53000,
    "deferredincometaxliabilities": 53000,
    "valuationallowancedeferredtaxassetchangeinamount": 13100000,
    "valuationallowancedeferredtaxassetchangenetamount": 13100000,
    "operatinglosscarryforwards": 48700000,
    "operatinglosscarryforwardsnonexpireportion": 44200000,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2034,
    "cumulativechangeinownershippercentage": 0.5,
    "periodforcumulativechangeinownership": "P3Y"
  }
]